GO:0006706 steroid catabolic process: Steroid Breakdown Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006706 (steroid catabolic process) describes the chemical reactions and pathways that break down steroids, compounds with a 1,2-cyclopentanoperhydrophenanthrene nucleus.
• Steroid catabolism is essential for clearing hormones, generating bile acids, and eliminating sterols; its disruption contributes to endocrine, metabolic, and adrenal diseases [2, 6, 8].
• Key enzymes include CYP family members (e.g., CYP3A4, CYP7A1, CYP11B1, CYP17A1, CYP21A2) and hydroxysteroid dehydrogenases (e.g., HSD3B2, HSD11B2, AKR1C3) [2, 3, 6].
• Steroid catabolism occurs mainly in the liver (bile acid synthesis, phase I/II modifications), but also in adrenal, gonadal, and peripheral tissues [2, 7].
• Defects in steroid catabolic enzymes cause disorders such as congenital adrenal hyperplasia, adrenal insufficiency, and androgen excess [6, 8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise dissection of steroid catabolic gene function in vitro and in vivo [1, 4].
Description
Steroid catabolic process (GO:0006706) is the biological process that breaks down steroids, a class of lipophilic molecules built on a 1,2-cyclopentanoperhydrophenanthrene nucleus. This process is fundamental to human physiology because it controls the clearance of steroid hormones, the production of bile acids, and the elimination of cholesterol-derived metabolites [2, 3]. The term encompasses oxidative, reductive, and conjugative reactions that convert active steroids into more polar, excretable forms [2, 7]. Researchers study steroid catabolism to understand endocrine disorders, metabolic diseases, and the pharmacokinetics of steroidal drugs [6, 8]. The pathway is also a target for microbial biotransformations used in industrial steroid production [1, 4]. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0006706, its genes, mechanisms, and experimental models.
steroid catabolic process At A Glance
| GO ID | GO:0006706 |
|---|---|
| GO term | steroid catabolic process |
| Ontology | biological_process |
| Synonym | steroid breakdown, steroid catabolism, steroid degradation |
| Major function | Breakdown of steroids with a 1,2-cyclopentanoperhydrophenanthrene nucleus |
| Key tissues | Liver, adrenal cortex, gonads, peripheral tissues |
| Key enzymes | Cytochrome P450s, hydroxysteroid dehydrogenases, conjugating enzymes |
| Related pathways | Steroid hormone biosynthesis, bile acid biosynthesis, drug metabolism |
What Is GO:0006706?
According to QuickGO, GO:0006706 (steroid catabolic process) is defined as the chemical reactions and pathways resulting in the breakdown of steroids, compounds with a 1,2-cyclopentanoperhydrophenanthrene nucleus. Synonyms include steroid breakdown, steroid catabolism, and steroid degradation. In practice, this process includes enzymatic modifications such as hydroxylation, oxidation, reduction, and conjugation that increase steroid solubility and facilitate excretion [2, 7].
Why Is steroid catabolic process Important in Cell Biology?
Steroid catabolic process is critical for maintaining hormonal balance, eliminating toxic sterols, and producing bile acids necessary for lipid digestion [2, 3]. Dysregulation of this process leads to endocrine disorders such as congenital adrenal hyperplasia, adrenal insufficiency, and androgen excess, and it influences the metabolism of steroidal drugs [6, 8]. Understanding steroid catabolism also has industrial relevance, as microbial steroid biotransformations are used to produce pharmaceutical steroids [1, 4].
• Controls clearance of cortisol, aldosterone, and sex steroids, preventing hormonal imbalance [2, 6].
• Generates bile acids from cholesterol, essential for fat absorption and cholesterol homeostasis.
• Inactivates and eliminates steroidal drugs, affecting pharmacokinetics and drug interactions [2, 7].
• Defects cause congenital adrenal hyperplasia and other steroidogenesis disorders.
• Altered steroid catabolism is linked to adrenal tumors and androgen excess conditions.
• Provides biomarkers for adrenal disease through serum and urine steroid metabolomes [2, 8].
• Enables microbial biotransformation for industrial steroid production [1, 4].
• Serves as a model for studying enzyme evolution and metabolic diversity.
• Impacts immune and metabolic regulation via steroid hormone levels.
• Offers targets for therapeutic modulation in hormone-dependent cancers.
What Happens During steroid catabolic process?
Phase I: Oxidative and Reductive Modifications
In simple terms: The body first modifies steroids by adding or removing chemical groups to make them more water-soluble.
Phase I reactions are catalyzed primarily by cytochrome P450 enzymes and hydroxysteroid dehydrogenases, which introduce hydroxyl groups or oxidize/reduce steroid rings [2, 3]. For example, CYP3A4 hydroxylates steroids, while HSD3B2 and HSD11B2 interconvert active and inactive forms [2, 6]. These modifications prepare steroids for subsequent conjugation and excretion.
Phase II: Conjugation Reactions
In simple terms: The modified steroids are tagged with molecules like sulfate or glucuronide to make them even more soluble.
Conjugation with sulfate or glucuronide is carried out by sulfotransferases (SULTs) and UDP-glucuronosyltransferases (UGTs), respectively [2, 7]. Steroid disulfates are a notable example of doubly conjugated steroids with unique physiological roles. These conjugates are more polar and are readily excreted in urine or bile [2, 7].
Bile Acid Synthesis from Cholesterol
In simple terms: The liver converts cholesterol into bile acids, which are then excreted to help digest fats.
Cholesterol catabolism to bile acids is a major branch of steroid catabolic process, initiated by CYP7A1 and followed by multiple enzymatic steps [2, 3]. This pathway accounts for a significant portion of daily cholesterol turnover and is regulated by feedback mechanisms involving FXR and LXR.
Tissue-Specific Catabolism
In simple terms: Different organs break down steroids in their own way to control local hormone levels.
Peripheral tissues such as adipose, prostate, and breast express enzymes like AKR1C3 and SRD5A that locally inactivate or activate steroids [2, 8]. The adrenal cortex also catabolizes steroids through CYP11B1 and CYP11B2. This tissue-specific catabolism fine-tunes hormone action.
Excretion and Clearance
In simple terms: After modification, steroids are removed from the body through urine or feces.
Conjugated steroids are transported by ABC transporters and excreted via renal or biliary routes [2, 7]. Urinary steroid metabolome profiling reflects the overall activity of steroid catabolic pathways and is used clinically to diagnose adrenal disorders [2, 8].
Key Genes Involved in GO:0006706 steroid catabolic process
The following genes encode enzymes and transporters directly involved in steroid catabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP3A4 | Oxidizes steroids and steroidal drugs | Drug metabolism and steroid clearance |
| CYP7A1 | Initiates bile acid synthesis from cholesterol | Cholesterol homeostasis and bile acid research [2, 3] |
| CYP11B1 | Catalyzes cortisol synthesis and catabolism | Adrenal disease and hypertension |
| CYP11B2 | Aldosterone synthesis and catabolism | Primary aldosteronism research |
| CYP17A1 | Androgen and glucocorticoid metabolism | Congenital adrenal hyperplasia |
| CYP21A2 | 21-hydroxylation in steroid catabolism | Congenital adrenal hyperplasia |
| HSD3B2 | 3β-hydroxysteroid dehydrogenase | Adrenal and gonadal steroid disorders |
| HSD11B2 | Inactivates cortisol to cortisone | Hypertension and metabolic syndrome |
| AKR1C3 | Reduces steroids and prostaglandins | Prostate cancer and androgen excess |
| SRD5A1 | 5α-reductase, inactivates testosterone | Androgen metabolism research |
| SULT2A1 | Sulfonates steroids | Steroid conjugate physiology [5, 7] |
| UGT2B7 | Glucuronidates steroids | Drug metabolism and excretion |
| ABCB11 | Bile acid export pump | Cholestasis and bile acid transport |
| SLCO1B1 | Uptake transporter for steroids | Hepatic steroid clearance |
| NR1H4 (FXR) | Regulates bile acid synthesis | Feedback control of steroid catabolism |
| NR1H3 (LXR) | Regulates cholesterol catabolism | Lipid metabolism research |
| STAR | Cholesterol transport for steroidogenesis | Steroidogenic tissue research |
How Is steroid catabolic process Regulated?
Steroid catabolic process is regulated at multiple levels. Nuclear receptors such as FXR (NR1H4) and LXR (NR1H3) control bile acid synthesis and cholesterol catabolism through feedback loops. In the adrenal cortex, ACTH and angiotensin II regulate CYP11B1 and CYP11B2 expression, thereby modulating steroid catabolism. Peripheral enzymes like HSD11B2 are regulated by cytokines and growth factors, linking steroid catabolism to inflammation and metabolism. Additionally, sulfotransferases and glucuronosyltransferases are induced by xenobiotics via PXR and CAR, affecting steroid clearance [2, 7].
steroid catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP21A2 | Congenital adrenal hyperplasia | Knockout or point-mutation in adrenal cell lines |
| HSD11B2 | Hypertension and mineralocorticoid excess | Knockout mouse or overexpression in renal cells |
| CYP11B1 | Adrenal hyperplasia and Cushing's | Knock-in of patient mutations in H295R cells |
| AKR1C3 | Prostate cancer and androgen excess | Knockout in LNCaP cells and xenografts |
| CYP7A1 | Cholestasis and dyslipidemia | Liver-specific knockout mouse |
Congenital Adrenal Hyperplasia (CAH)
CAH is caused by defects in steroidogenic enzymes, most commonly CYP21A2, leading to impaired cortisol synthesis and androgen excess. Disrupted steroid catabolism contributes to the accumulation of precursor steroids and clinical manifestations such as virilization.
Adrenal Tumors and Cushing's Syndrome
Altered steroid catabolism is observed in adrenal adenomas and carcinomas, where steroid metabolome profiling reveals distinct patterns of hormone excess. Cushing's syndrome results from excessive cortisol, often due to impaired negative feedback and catabolism.
Metabolic and Cardiovascular Disorders
HSD11B2 deficiency leads to apparent mineralocorticoid excess, causing hypertension and hypokalemia due to impaired cortisol inactivation. Bile acid catabolism defects can cause cholestasis and dyslipidemia [2, 3].
Hormone-Dependent Cancers
Intratumoral steroid catabolism modulates androgen and estrogen levels in prostate and breast cancers. AKR1C3 and SRD5A1 are implicated in castration-resistant prostate cancer.
From steroid catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CYP21A2 impair cortisol catabolism? | CRISPR knockout in H295R adrenal cells |
| How does HSD11B2 point mutation affect cortisol inactivation? | Point-mutation knock-in in HEK293 cells |
| Can overexpression of AKR1C3 drive androgen independence? | Overexpression in LNCaP prostate cancer cells |
| What is the role of CYP7A1 in bile acid catabolism? | Liver-specific knockout mouse |
| How does SULT2A1 sulfation affect steroid clearance? | Tagged knock-in for live-cell imaging |
| Does FXR regulate steroid catabolic genes? | CRISPR knockout of NR1H4 in hepatocytes |
How to Study the steroid catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS steroid profiling | Concentrations of steroid metabolites | Diagnosis of adrenal disease [2, 8] |
| Enzyme activity assay | Catalytic rate of steroid conversion | Characterization of CYP and HSD enzymes |
| CRISPR knockout screen | Genes affecting steroid catabolism | Discovery of novel regulators |
| RNA-seq | Transcript levels of catabolic genes | Regulation by FXR/LXR |
| Proteomics | Protein expression and modifications | Tissue-specific enzyme mapping |
| Immunofluorescence | Subcellular localization of enzymes | Organelle-specific catabolism |
| Bile acid quantification | Bile acid pool composition | Cholesterol catabolism studies |
| Steroid conjugate analysis | Sulfated/glucuronidated steroids | Phase II metabolism research [5, 7] |
Steroid Metabolome Profiling
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) measures serum and urine steroid metabolites, providing a comprehensive readout of steroid catabolic pathway activity [2, 8]. This method is used clinically to diagnose adrenal disorders and monitor treatment.
Enzyme Activity Assays
Recombinant enzymes or cell lysates are incubated with steroid substrates, and product formation is quantified by HPLC or MS [1, 4]. These assays determine kinetic parameters and inhibitor sensitivity of catabolic enzymes.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout libraries can identify genes required for steroid catabolism, such as transporters and enzymes. Hits are validated by targeted knockout and metabolite analysis.
Transcriptomics and Proteomics
RNA-seq and proteomics reveal expression changes in steroid catabolic genes under different conditions, such as hormone stimulation or disease states [2, 3]. These approaches uncover regulatory networks involving nuclear receptors.
How CRISPR Can Be Used to Study GO:0006706 steroid catabolic process
Knockout
CRISPR knockout of steroid catabolic genes such as CYP21A2 or HSD11B2 in cell lines (e.g., H295R, HEK293) creates loss-of-function models to study enzyme necessity and metabolic consequences [1, 6]. These models are validated by steroid profiling and can reveal compensatory pathways.
Point Mutation
Introducing patient-specific point mutations (e.g., in CYP21A2 or HSD11B2) via CRISPR base editing or homology-directed repair recapitulates disease alleles and allows structure-function analysis. Such models help determine the impact of missense variants on enzyme activity.
Knock-in
Knock-in of tagged versions (e.g., GFP or HA) of catabolic enzymes enables live-cell imaging and protein interaction studies. Knock-in of regulatory elements can also reveal transcriptional control of steroid catabolism.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like AKR1C3 or CYP7A1 boosts catabolic flux, useful for studying gain-of-function effects in cancer and metabolic models. Overexpression models help identify rate-limiting steps.
How EDITGENE Supports steroid catabolic process Research
Researchers studying steroid catabolic process-related genes often need to determine whether a candidate gene is causally involved in steroid breakdown, hormone clearance, or disease progression. Precise genetic models are essential to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for steroid catabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| CYP3A4 Knockout HEK293 Cell Line | EDJ-KQ1389 | Human | 1576 | Details Get a Quote |
| SRD5A2 Knockout HEK293 Cell Line | EDJ-KQ1895 | Human | 6716 | Details Get a Quote |
| CYP1B1 Knockout HEK293 Cell Line | EDJ-KQ2285 | Human | 1545 | Details Get a Quote |
| HSD11B1 Knockout HEK293 Cell Line | EDJ-KQ2543 | Human | 3290 | Details Get a Quote |
| CYP1A1 Knockout HEK293 Cell Line | EDJ-KQ3897 | Human | 1543 | Details Get a Quote |
| STS Knockout HEK293 Cell Line | EDJ-KQ4101 | Human | 412 | Details Get a Quote |
| CYP1A2 Knockout HEK293 Cell Line | EDJ-KQ4399 | Human | 1544 | Details Get a Quote |
| CYP1A1 Knockout HCT 116 Cell Line | EDJ-KQ26114 | Human | 1543 | Details Get a Quote |
| CYP1B1 Knockout A-549 Cell Line | EDJ-KQ22636 | Human | 1545 | Details Get a Quote |
| CYP1B1 Knockout HCT 116 Cell Line | EDJ-KQ22637 | Human | 1545 | Details Get a Quote |
| CYP1B1 Knockout HeLa Cell Line | EDJ-KQ22638 | Human | 1545 | Details Get a Quote |
| STS Knockout A-549 Cell Line | EDJ-KQ26485 | Human | 412 | Details Get a Quote |
| STS Knockout HeLa Cell Line | EDJ-KQ26486 | Human | 412 | Details Get a Quote |
| CYP1A1 Knockout HeLa Cell Line | EDJ-KQ53039 | Human | 1543 | Details Get a Quote |
| CYP1A2 Knockout HeLa Cell Line | EDJ-KQ53040 | Human | 1544 | Details Get a Quote |
Displaying Records 1 To 15 Of 28 Records
Frequently Asked Questions About steroid catabolic process
What is steroid catabolic process (GO:0006706)?
It is the biological process that breaks down steroids, compounds with a 1,2-cyclopentanoperhydrophenanthrene nucleus, into more polar metabolites for excretion.
What genes are involved in steroid catabolic process?
Key genes include CYP3A4, CYP7A1, CYP11B1, CYP17A1, CYP21A2, HSD3B2, HSD11B2, AKR1C3, SULT2A1, and UGT2B7 [2, 3, 6].
Where does steroid catabolism occur in the body?
It occurs mainly in the liver, but also in the adrenal cortex, gonads, adipose tissue, and other peripheral tissues [2, 8].
What diseases are linked to defects in steroid catabolism?
Congenital adrenal hyperplasia, adrenal insufficiency, hypertension, and hormone-dependent cancers are linked to defects in steroid catabolic enzymes [6, 8].
How is steroid catabolic process regulated?
It is regulated by nuclear receptors (FXR, LXR), hormones (ACTH, angiotensin II), and xenobiotic sensors (PXR, CAR) [2, 3, 8].
What are the products of steroid catabolism?
Products include bile acids, sulfated and glucuronidated steroids, and other polar metabolites excreted in urine or bile [2, 7].
Why is steroid catabolism important for drug metabolism?
Many steroidal drugs are inactivated by catabolic enzymes like CYP3A4 and UGTs, affecting drug efficacy and clearance [2, 7].
How can CRISPR help study steroid catabolic process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of catabolic genes to test their function [1, 4].
What methods are used to measure steroid catabolism?
LC-MS/MS steroid profiling, enzyme activity assays, and CRISPR screens are commonly used [1, 2, 8].
What is the role of sulfation in steroid catabolism?
Sulfation by SULT enzymes increases steroid solubility and facilitates excretion, with steroid disulfates having unique roles [5, 7].
Conclusion
Steroid catabolic process (GO:0006706) is a vital biological pathway that controls hormone clearance, bile acid synthesis, and sterol elimination. Its dysregulation underlies numerous endocrine and metabolic diseases, making it a key research area. Advances in CRISPR-based models and metabolomic profiling continue to illuminate the enzymes and regulatory networks involved, offering new opportunities for therapeutic intervention and industrial applications.
References
- 1. Donova MV. 2017. Steroid Bioconversions.. Methods Mol Biol 1645:1-13 PMID: 28710617
- 2. Schiffer L et al.. 2019. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.. J Steroid Biochem Mol Biol 194:105439 PMID: 31362062
- 3. Miller WL. 2017. Steroidogenesis: Unanswered Questions.. Trends Endocrinol Metab 28(11):771-793 PMID: 29031608
- 4. Sedlaczek L. 1988. Biotransformations of steroids.. Crit Rev Biotechnol 7(3):187-236 PMID: 3064921
- 5. Lightning TA et al.. 2021. Steroid disulfates - Sulfation double trouble.. Mol Cell Endocrinol 524:111161 PMID: 33453296
- 6. Biason-Lauber A et al.. 2010. Defects of steroidogenesis.. J Endocrinol Invest 33(10):756-66 PMID: 20190554
- 7. Vítků J et al.. 2023. Steroid Conjugates and Their Physiological Role.. Physiol Res 72(S4):S317-S322 PMID: 38116768
- 8. Rege J et al.. 2019. Steroid biomarkers in human adrenal disease.. J Steroid Biochem Mol Biol 190:273-280 PMID: 30707926
